FIGURE 6: PATENT TYPES FOR SEMAGLUTIDE FIGURE 7: ANNUAL PATENT FILINGS FOR SEMAGLUTIDE FIGURE 8: DURATION OF PATENT PROTECTION FOR SEMAGLUTIDE TIRZEPATIDE Tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight loss, is a newer entrant to the GLP-1 receptor agonist market
Mistake 5: storing the vial improperly Leaving the vial on a countertop, in a car, near a heat source, or anywhere unrefrigerated for extended periods degrades the medication
Step 4: hold for minimum two minutes This is where most people fail
Lilly's weight-loss pill, Foundayo, was launched in April following its U.S
Who Should Avoid Taking Ozempic
But amidst that clamour there is a significant risk of some producers taking advantage of the proliferation to sell unauthorised versions of the drugs, or using improper marketing practices to gain an unfair and potentially unsafe for patients advantage